Commentary
Podcast
Episode 121: Understanding the Potential Cardiovascular Benefits of Low-Sodium Oxybate
Author(s):
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Phil Jochelson, MD. [LISTEN TIME: 20 minutes]
Episode 121 of the NeurologyLive® Mind Moments® podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.
The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.
In this episode, "Understanding the Potential Cardiovascular Benefits of Low-Sodium Oxybate," Phil Jochelson, MD, therapeutic head for Clinical Development Neuroscience at Jazz Pharmaceuticals, sat down to discuss the phase 4 XYLO study, a randomized controlled study evaluating the effects of switching from high-sodium to low-sodium oxybate on blood pressure in patients with narcolepsy. Jochelson gave some insight regarding the conduct of the trial, including end points, objectives, and patient demographics, as well as some of the benefits to studying blood pressure and cardiovascular risks. In addition, he discussed enhancements to narcolepsy care through low-sodium oxybate, the importance of unique studies like XYLO, and the need to educate clinicians on sodium load and its risks.
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
- EU Regulatory Review Adopts Negative Opinion of Lecanemab as Treatment for Alzheimer Disease
- GLP-1 Agonist Liraglutide Shows Protective Effects on Alzheimer Disease in Phase 2 Trial
- FDA Approves Carbidopa/Levodopa ER Capsules Formulation IPX203 for Parkinson Disease
EPISODE BREAKDOWN
- 1:15 – Reasons behind the XYLO study and links between high sodium intake and cardiovascular risk
- 4:45 – Patient demographics; inclusion and exclusion criterias
- 6:40 – Neurology News Minute
- 9:25 – Overview of XYLO and determining what a successful study looks like
- 15:30 – Improved understanding of the benefits of low-sodium oxybate
Click here to subscribe to the Mind Moments podcast. Be sure to leave a rating and review for the show. Thanks for listening!
Hoping to listen on your favorite podcast app? See below:
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
